NAPHAZOLINE HCL
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | NAPHAZOLINE HCL |
| DrugBank ID | DB06711 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 22 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| open-angle glaucoma | TxGNN Knowledge Graph | L5 |
| peripheral vascular disease | TxGNN Knowledge Graph | L5 |
| brain ischemia | TxGNN Knowledge Graph | L5 |
| small intestine cancer | TxGNN Knowledge Graph | L5 |
| adrenal gland pheochromocytoma | TxGNN Knowledge Graph | L5 |
| phaeochromocytoma | TxGNN Knowledge Graph | L5 |
| duodenum cancer | TxGNN Knowledge Graph | L5 |
| peripheral arterial disease | TxGNN Knowledge Graph | L5 |
| heart cancer | TxGNN Knowledge Graph | L5 |
| transient ischemic attack (disease) | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11